<DOC>
	<DOCNO>NCT02696135</DOCNO>
	<brief_summary>Hypertrophic cardiomyopathy ( HCM ) one common inherit cardiac disease , prevalence âˆ¼0.2 % . The disease affect age group , mark clinical heterogeneity , range normal life span without symptom poor outcome sudden cardiac death ( SCD ) , advanced heart failure , stroke .</brief_summary>
	<brief_title>The Chinese Hypertrophic Cardiomyopathy Study ( CHCS )</brief_title>
	<detailed_description>The investigator ' research group determine prevalence hypertrophic cardiomyopathy China via epidemiologic investigation perform 8080 adult nine community across nine province China October 2001 February 2002 , start investigate Genotype-phenotype correlation . The investigator find hot mutation Chinese new relate gene different race , also uncovered presence multiple rare variant sarcomere gene risk factor malignant outcome HCM . The investigator intent observe refine clinical genetic feature Chinese patient HCM reveal risk factor prediction model prognosis .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>In accordance diagnosis hypertrophic cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Hypertrophic cardiomyopathy</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Stroke</keyword>
</DOC>